Normal view MARC view ISBD view

Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors.

Sisson, James C

Theranostics: evolution of the radiopharmaceutical meta-iodobenzylguanidine in endocrine tumors. [electronic resource] - Seminars in nuclear medicine May 2012 - 171-84 p. digital

Publication Type: Journal Article; Review

ISSN: 1558-4623

Standard No.: 10.1053/j.semnuclmed.2011.11.004 doi

Subjects--Topical Terms:
3-Iodobenzylguanidine--adverse effects
Clinical Trials as Topic
Endocrine Gland Neoplasms--diagnosis
Humans
Radiopharmaceuticals--adverse effects
Treatment Outcome

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)